• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.丙型肝炎病毒包膜在人类中的进化加速与急性感染向慢性感染转变过程中体液免疫选择的进展一致。
J Virol. 2010 May;84(10):5067-77. doi: 10.1128/JVI.02265-09. Epub 2010 Mar 3.
2
Prevalence of HCV HVR1 insertions and their role in antibody evasion.丙型肝炎病毒高变区1(HCV HVR1)插入的流行率及其在抗体逃逸中的作用。
Hepatology. 2025 Jul 1;82(1):199-211. doi: 10.1097/HEP.0000000000001114. Epub 2024 Oct 8.
3
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy.急性丙型肝炎病毒结构基因序列作为持续性病毒血症的预测指标:高变区1作为诱饵
J Virol. 1999 Apr;73(4):2938-46. doi: 10.1128/JVI.73.4.2938-2946.1999.
4
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
5
Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees.黑猩猩体内丙型肝炎病毒复制过程中高变区1序列的稳定性
J Virol. 2000 Apr;74(7):3058-66. doi: 10.1128/jvi.74.7.3058-3066.2000.
6
Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units.隔离作为血液透析单位控制丙型肝炎病毒(HCV)感染传播的一种策略。
Cochrane Database Syst Rev. 2016 Aug 11;2016(8):CD006420. doi: 10.1002/14651858.CD006420.pub2.
7
Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.急性丙型肝炎感染的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD011644. doi: 10.1002/14651858.CD011644.pub2.
8
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
9
Humoral immune response in acute hepatitis C virus infection.急性丙型肝炎病毒感染中的体液免疫反应。
Clin Infect Dis. 2005 Sep 1;41(5):667-75. doi: 10.1086/432478. Epub 2005 Jul 22.
10
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.

引用本文的文献

1
The association between drug injection duration and hepatitis C prevalence among people who inject drugs in Iran.伊朗注射吸毒者中药物注射时长与丙型肝炎患病率之间的关联。
Sci Rep. 2025 Mar 25;15(1):10208. doi: 10.1038/s41598-025-94867-5.
2
Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection.丙型肝炎病毒高变区1抗体阻断E2-SR-B1相互作用以抑制病毒感染。
iScience. 2023 Mar 16;26(4):106421. doi: 10.1016/j.isci.2023.106421. eCollection 2023 Apr 21.
3
Hepatitis C Vaccination: Where We Are and Where We Need to Be.丙型肝炎疫苗接种:我们所处的位置以及我们需要达到的目标。
Pathogens. 2021 Dec 14;10(12):1619. doi: 10.3390/pathogens10121619.
4
Challenges and Prospects of Plant-Derived Oral Vaccines against Hepatitis B and C Viruses.植物源乙肝和丙肝病毒口服疫苗的挑战与前景
Plants (Basel). 2021 Sep 28;10(10):2037. doi: 10.3390/plants10102037.
5
Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial.下一步在哪里?首个丙型肝炎疫苗疗效试验后的研究方向。
Viruses. 2021 Jul 13;13(7):1351. doi: 10.3390/v13071351.
6
Mechanisms of HCV resistance to broadly neutralizing antibodies.HCV 对广泛中和抗体耐药的机制。
Curr Opin Virol. 2021 Oct;50:23-29. doi: 10.1016/j.coviro.2021.07.003. Epub 2021 Jul 28.
7
Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing.利用单基因组测序评估感染 HIV 的男男性行为者中丙型肝炎的传播途径。
PLoS One. 2020 Jul 15;15(7):e0235237. doi: 10.1371/journal.pone.0235237. eCollection 2020.
8
Hepatitis C virus vaccine design: focus on the humoral immune response.丙型肝炎病毒疫苗设计:关注体液免疫应答。
J Biomed Sci. 2020 Jul 6;27(1):78. doi: 10.1186/s12929-020-00669-4.
9
Hepatitis C Virus Vaccine: Challenges and Prospects.丙型肝炎病毒疫苗:挑战与前景
Vaccines (Basel). 2020 Feb 17;8(1):90. doi: 10.3390/vaccines8010090.
10
Challenges and Promise of a Hepatitis C Virus Vaccine.丙型肝炎病毒疫苗的挑战与前景。
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a036947. doi: 10.1101/cshperspect.a036947.

本文引用的文献

1
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.对传播/奠基者病毒的首次T细胞反应有助于控制HIV-1感染中的急性病毒血症。
J Exp Med. 2009 Jun 8;206(6):1253-72. doi: 10.1084/jem.20090365. Epub 2009 Jun 1.
2
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.丙型肝炎病毒E2中位于CD81结合位点之外的突变会导致病毒逃脱广泛中和抗体的作用,但会损害病毒的感染性。
J Virol. 2009 Jun;83(12):6149-60. doi: 10.1128/JVI.00248-09. Epub 2009 Mar 25.
3
Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.在丙型肝炎病毒急性感染期间,来自中和抗体的选择压力驱动序列进化。
Gastroenterology. 2009 Jun;136(7):2377-86. doi: 10.1053/j.gastro.2009.02.080. Epub 2009 Mar 17.
4
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.急性感染期间丙型肝炎病毒特异性T细胞上程序性死亡-1水平升高与病毒持续存在相关,且在慢性感染期间需要保留同源抗原。
J Immunol. 2008 Dec 15;181(12):8215-25. doi: 10.4049/jimmunol.181.12.8215.
5
Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.丙型肝炎病毒逃避HLA - B*08限制性CD8 T细胞与适应性代价相关。
J Virol. 2008 Dec;82(23):11803-12. doi: 10.1128/JVI.00997-08. Epub 2008 Sep 24.
6
Acute hepatitis C.急性丙型肝炎
Lancet. 2008 Jul 26;372(9635):321-32. doi: 10.1016/S0140-6736(08)61116-2.
7
Hepatitis C virus entry and neutralization.丙型肝炎病毒的进入与中和
Clin Liver Dis. 2008 Aug;12(3):693-712, x. doi: 10.1016/j.cld.2008.03.008.
8
Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.先前感染过的黑猩猩在再次接触相同的丙型肝炎病毒毒株后,不能持续获得针对再感染或持续感染的保护。
J Virol. 2008 Aug;82(16):8183-95. doi: 10.1128/JVI.00142-08. Epub 2008 Jun 11.
9
Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.丙型肝炎病毒免疫显性CD8表位在群体水平上的进化力分析。
J Virol. 2008 Apr;82(7):3438-51. doi: 10.1128/JVI.01700-07. Epub 2008 Jan 23.
10
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.在存在中和抗体的情况下丙型肝炎病毒在肝癌细胞中的细胞间传播
Hepatology. 2008 Jan;47(1):17-24. doi: 10.1002/hep.21959.

丙型肝炎病毒包膜在人类中的进化加速与急性感染向慢性感染转变过程中体液免疫选择的进展一致。

Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.

机构信息

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, 855 N. Wolfe St., suite 530, Baltimore, MD 21205, USA.

出版信息

J Virol. 2010 May;84(10):5067-77. doi: 10.1128/JVI.02265-09. Epub 2010 Mar 3.

DOI:10.1128/JVI.02265-09
PMID:20200239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2863818/
Abstract

During the transition from acute to chronic infection in individuals persistently infected with hepatitis C virus (HCV), cellular responses initiate within the first 6 months of primary infection and collapse thereafter, whereas humoral responses activate later during the chronic phase. Whether and how this deviation of immune responses specifically influences HCV evolution are unknown. To determine the pattern of HCV evolution during this critical period, we conducted extensive sequence analysis on annual clonal hemigenomic sequences for up to 3 years in six well-characterized subjects, using statistical methods that accounted for repeated measures. Significantly different evolutionary rates were observed in envelope versus nonenvelope genes, with an increasing rate of nonsynonymous change (dN) in envelope genes and a stable dN in nonenvelope genes (P = 0.006). The ratio of the envelope to nonenvelope nonsynonymous rate increased from 2 in year 1 to 5 in years 2 and 3. Centripetal changes (reversions toward matching of the worldwide subtype 1a consensus sequence) were frequently observed during the 3-year transition from acute infection to chronicity, even in the presence of neutralizing antibody (NAb) pressure. Remarkably, sequences of hypervariable region 1 (HVR1) remained stable for up to 21 months in the absence of NAb pressure in one subject, followed by rapid changes that were temporally associated with the detection of NAb responses, which strongly suggests that HVR1 evolution is shaped by NAb pressure. These data provide the first systematic estimates of HCV evolutionary rates in multiple genes during early infection in vivo and provide additional evidence for deterministic, rather than random, evolution of HCV.

摘要

在慢性丙型肝炎病毒(HCV)感染者从急性感染向慢性感染的转变过程中,细胞免疫反应在初次感染的前 6 个月内启动,此后便崩溃,而体液免疫反应则在慢性期晚期激活。这种免疫反应的偏差是否以及如何具体影响 HCV 的进化尚不清楚。为了确定在这一关键时期 HCV 进化的模式,我们对六名特征明确的研究对象进行了长达 3 年的每年一次的克隆半基因组序列的广泛序列分析,采用了考虑重复测量的统计方法。包膜基因与非包膜基因的进化速率明显不同,包膜基因的非同义突变率(dN)呈递增趋势,而非包膜基因的 dN 则保持稳定(P = 0.006)。包膜基因与非包膜基因的非同义率比值从第 1 年的 2 增加到第 2 年和第 3 年的 5。在从急性感染向慢性感染的 3 年转变过程中,即使存在中和抗体(NAb)压力,也经常观察到向全球 1a 亚型共识序列趋同的中心性变化(回复突变)。值得注意的是,在一个没有 NAb 压力的研究对象中,HVR1 序列在长达 21 个月的时间内保持稳定,随后迅速发生变化,与 NAb 反应的检测时间相关,这强烈表明 HVR1 的进化受到 NAb 压力的影响。这些数据首次提供了 HCV 在体内早期感染多个基因的进化速率的系统估计,并为 HCV 的确定性进化而非随机进化提供了额外的证据。